Mode
Text Size
Log in / Sign up
N/A N=50 Other

RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators

Cardiomyopathy · Cardiac Arrhythmia · Heart Failure · Chronic Thromboembolic Pulmonary Hypertension

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcome: Primary: Pacing Mode Changes Between Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure — 29; 29; 8; 8 participants — p=1.0

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
RF Assure Scanning (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Diego
Primary completion
Mar 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Pacing Mode Changes Between Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
29; 29; 8; 8; 2; 2 1.0
PRIMARY
Pacing Polarity Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
40; 40; 5; 5; 3; 3
PRIMARY
Base Rate Measurement Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned w/ RF Assure
60; 60
PRIMARY
Max Tracking Rate Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
130; 130
PRIMARY
Atrio-ventricular (AV) Delay Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
230; 230; 250; 250
PRIMARY
Battery Capacity Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
2.745; 2.744
PRIMARY
Pacing Impedance Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
500.1; 495.1; 531.9; 530.6; 592.8; 610.1
PRIMARY
Shock Impedance Changes With Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
51.30; 51.5; 53.45; 53.70
PRIMARY
Changes in P & R Wave Measurements in Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
2.5; 2.469; 10.73; 10.76
PRIMARY
Capture Threshold Changes With Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure
0.806; 0.819; 0.955; 0.972; 2.616; 2.320

Summary

If a surgical sponge is mistakenly left inside a patient's body after a surgical procedure, it can cause a serious infection. To prevent this from happening, a new device has been developed that uses radiofrequency (RF) signals to detect the presence of surgical sponges inside the body. The device is now being used routinely to make sure that no sponges are left inside a patient at the end of an operation. However, the RF device has not been implemented in procedures for patients with cardiac implantable electronic devices (CIEDs). While the device is FDA approved for use, there is a theoretical concern that the radiofrequency signals used to detect the sponges will change the settings on the pacemaker or the defibrillator. Changing the settings on a pacemaker might make it pace the heart too quickly or too slowly, while changing the settings on a defibrillator might cause unnecessary shocks or prevent it from shocking the heart if the patient were to have cardiac arrest. The purpose of this study is to test whether the radiofrequency device used to detect sponges can cause a clinically significant change to the settings on pacemakers and defibrillators. To minimize potential risk, the device will be tested only on patients who are having the pacemaker or defibrillator removed or replaced as part of their regular medical care, either because it is infected or because the battery has worn out. Before the pacemaker or defibrillator is removed, the settings will be carefully and completely recorded and the radiofrequency device will be used to scan the body for sponges as it would be done during normal operation. After the pacemaker or defibrillator is taken out, the settings will again be recorded and compared to the settings before the scan. In a standard device removal procedure, no clinically significant change in CIED settings would be expected. If a new pacemaker or defibrillator is implanted in the patient, it will not be exposed to the detection device at all. We will also test whether the RF device has any effect on temporary pacemakers that patients may receive after open heart surgery. We plan to perform testing in a total of 50 patients, 40 with permanent pacemakers or defibrillators and 10 with temporary pacemakers.

Eligibility Criteria

Inclusion Criteria

  • Patients must be at least 18 years of age
  • Patients must be willing and able to provide consent
  • Patients must be eligible for pacemaker/ICD removal or temporary pacemaker

Exclusion Criteria

  • Pregnancy
  • Inability or unwillingness to comply with the protocol
  • Medical condition that would limit study participation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02111980). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search